This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.86% per year. These returns cover a period from January 1, 1988 through February 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
Zacks News
Will China ETFs Gain on Better-Than-Expected Trade Data?
by Sweta Jaiswal, FRM
The recently-released encouraging trade data shows that China is gradually recovering from the coronavirus outbreak. However, slowing global economic growth remains a risk.
Is it the Right Time to Buy China ETFs? Let's Explore
by Sweta Jaiswal, FRM
China is still exposed to risks of a second wave of new coronavirus infections and falling global economic growth.
Will China ETFs Gain on New Round of Monetary Easing?
by Sweta Jaiswal, FRM
China's central bank joins the global efforts to support its ailing economy by resorting to monetary-easing policies.
5 International Equity ETFs That Topped S&P 500 in Q1
by Sanghamitra Saha
These international ETFs have outperformed the S&P 500 in the first quarter.
Should You Buy China ETFs as Coronavirus Cases Wane?
by Sweta Jaiswal, FRM
The coronavirus outbreak seems to be slowing down in the world's second largest economy.
ETFs at Risk as Coronavirus Hits China's Economy Hard
by Sweta Jaiswal, FRM
The latest economic data reveals how damaging the coronavirus outbreak has been for China's economy.
ETFs to Suffer as China's Q1 Growth Outlook Gets Gloomier
by Sweta Jaiswal, FRM
Analysts are getting more pessimistic about China's economic growth in the first quarter of 2020 as the coronavirus outbreak continues to intensify globally.
Most Actively Traded ETFs Over the Past 20 Days
by Sweta Killa
We have profiled 10 ETFs that have seen massive trading volumes over the past 20 days.
Will China ETFs Suffer as Coronavirus Dents Factory Output?
by Sweta Jaiswal, FRM
China's manufacturing output PMI hit the lowest level in record in February primarily due to the coronavirus outbreak.
China ETFs to Gain on New Stimuli to Combat Coronavirus
by Sweta Jaiswal, FRM
China's introduction of fresh stimuli to fight the impact of coronavirus on the economy instills confidence in investors.